• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Du Pont ramps up search for buyer

Article

Du Pont has begun the process of weeding out suitors for its medicalproducts business, according to the Wilmington, DE, company. Thefirm is sending out information on its medical products unitsto companies that it believes are qualified to buy the

Du Pont has begun the process of weeding out suitors for its medicalproducts business, according to the Wilmington, DE, company. Thefirm is sending out information on its medical products unitsto companies that it believes are qualified to buy the businesses,according to spokesperson Jayne Seebach Persico.

Industry speculation has run rampant as to the identity of abuyer for the units, which include the Du Pont Diagnostic Imagingfilm and digital imaging business. Some observers have suggestedthat a buyer has already been found, but those pundits are jumpingthe gun, Persico said.

"The field has been narrowed, but we do not have a buyerat this time," Persico said.

We don't anticipate selling or having a firm idea of who thebuyer is until the (Radiological Society of North America meeting).

Du Pont received 60 to 80 inquiries in the weeks after it announcedit was selling the medical products business to pay for the purchaseof its stock held by Seagram (SCAN 6/7/95). The company is determiningwhich of those candidates are qualified to continue in the process,which will require the signing of a confidentiality agreementbefore interested parties can receive additional information onthe medical products business.

Among the criteria Du Pont is using to size up potential buyersare the strategic business fit between Du Pont and the acquiringcompany, whether antitrust issues would interfere with an acquisition,and the company's treatment of employees and customers. Du Ponthopes to have the deal completed by early 1996, Persico said.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.